Maxillary sinus augmentation with platelet-rich plasma and fibrinogen cryoprecipitate: A tomographic pilot study

Implant Dentistry

Volumn 14, Issue 1, 2005, Pages 63-69

  Graziani, Filippo ^a   Ducci, Francesco ^a   Tonelli, Matteo ^a   El Askary, Abdel Salam ^b   Monier, Maha ^c   Gabriele, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF FLORIDA   (United States)

^c ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Bone; Fibrin glue; Grafts; Plasma; Wound healing

Indexed keywords

FIBRINOGEN;

BONE GRAFT; BONE REGENERATION; CONFERENCE PAPER; CRYOPRECIPITATION; EVALUATION; HUMAN; JAW; MAXILLA; MAXILLARY SINUS; PLASMA; POSTOPERATIVE PERIOD; THROMBOCYTE; THROMBOCYTE COUNT; TOMOGRAPHY;

ADULT; ALVEOLAR RIDGE AUGMENTATION; BLOOD PLATELETS; BONE REGENERATION; BONE TRANSPLANTATION; FACTOR VIII; FIBRINOGEN; GELS; HUMANS; MAXILLARY SINUS; MIDDLE AGED; PILOT PROJECTS; PLASMA; RADIOGRAPHY, PANORAMIC; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 16244374336     PISSN: 10566163     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.id.0000156387.35521.bf     Document Type: Conference Paper

References (50)

1. Marx R, Carlson E, Eichstaedt R, et al. Platelet-rich plasma. Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638-646.
2. Marx RE. Platelet-rich plasma: a source of multiple autologous growth factors for bone grafts. In: Lynch SE, Genco RJ, Marx RE, eds. Tissue Engineering. Applications in Maxillofacial Surgery and Periodontics. Chicago: Quintessence; 1999: 71-82.
3. Whitman DH, Berry RL, Green D. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997;55:1294-1299.
4. Marx RE. Platelet rich plasma (PRP); what is PRP and what is not PRP. Implant Dentistry. 2001;10:4:225-228.
5. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future site for implants. Int J Oral Maxillofac Implants. 1999;14:529-535.
6. Giannobile W. Periodontal tissue regeneration by polypeptide growth factors and gene transfer. In: Lynch SE, Genco RJ, Marx RE, eds. Tissue Engineering. Applications in Maxillofacial Surgery and Periodontics. Chicago: Quintessence; 1999: 231-243.
7. Howell TH, Fiorellini JP, Paquette DW, et al. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol. 1997;68:1186-1193.
8. American Academy of Periodontology Position Paper. The potential role of growth and differentiation factors in periodontal regeneration. J Periodontol. 1996;67:543-553.
9. Zhu Z, Lee CS, Tejeda KM, et al. Gene transfer and expression of platelet-derived growth factors modulate periodontal cellular activity. J Dent Res. 2001;80:892-897.
10. Cho MI, Lin WL, Genco RJ. Platelet-derived growth factor modulated guided tissue regenerative therapy. J Periodontol. 1995;66:522-530.
11. Wrana JL, Attisano L, Wieser R, et al. Mechanism of activation of the TGF-β receptor. Nature (Lond). 1994;370:341-346.
12. Lynch SE, Ruiz de Castilla G, et al. The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol. 1991;62: 458-467.
13. Lynch SE, Buser D, Hernandez RA, et al. Effects of the platelet-derived growth factor/insulin-like growth factor combination on bone regeneration around titanium dental implants. Results of a pilot study in beagle dogs. J Periodontol. 1991;62:710-716.
14. Safwat AM, Bush R. Intraoperative use of platelet-plasmapheresis in vascular surgery. J Clin Anesth. 2002;14:10-14.
15. Man D, Plosker H. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor-plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg. 2001;107:229-237.
16. Kashima I, Ueda T. Efficacy of autologous platelet-rich plasma in thoracic aortic aneurysm surgery. Jpn J Thorac Cardiovasc Surg. 2000;48:708-712.
17. Stover EP, Siegel LC. Platelet-rich plasma sequestration, with therapeutic platelet yields, reduces allogeneic transfusion in complex cardiac surgery. Anesth Analg. 2000;90:509-516.
18. Kassolis JD, Rosen PS, Reynolds MA. Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with freeze-dried bone allograft: case series. J Periodontol. 2000;71:1654-1661.
19. Sonneleitner D, Huemer P, Sullivan DY. A simplified technique for producing platelet-rich plasma and platelet concentrate for intraoral bone grafting techniques: a technical note. Int J Oral Maxillofac Implants. 2000;15:879-882.
20. Lekovic V, Camargo PM, Weinlaender M, et al. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study. J Periodontol. 2002;73:198-205.
21. Shanaman R, Filstein MR, Danesh-Meyer MJ. Localized ridge augmentation using GBR and platelet-rich plasma: case reports. Int J Periodontics Restorative Dent. 2000;21:345-355.
22. Rosemberg ES, Torosian J. Sinus grafting using platelet-rich plasma - initial case presentation. Pract Periodont Aesthet Dent. 2000;12:843-850.
23. Weibrich G, Kleis WK, Kunz-Kostomanolakis M, et al. Correlation of platelet concentration in platelet-rich plasma to the extraction method, age, sex, and platelet count of the donor. Int J Oral Maxillofac Implants. 2001;16:693-699.
24. Kim SG, Chung CH, Kim YK, et al. Use of particulate dentin-plaster of paris combination with/without platelet-rich plasma in the treatment of bone defects around implants. Int J Oral Maxillofac Implants. 2002;17:86-94.
25. Garg AK. Grafting materials in repair and restoration. In: Lynch SE, Genco RJ, Marx RE, eds. Tissue Engineering. Applications in Maxillofacial Surgery and Periodontics. Chicago: Quintessence; 1999: 83-101.
26. Buser D, Dula K, Hirt HP, et al. Lateral ridge augmentation using autografts and barrier membranes: a clinical study with 40 partially edentulous patients. J Oral Maxillofac Surg. 1996;54:420-432.
27. Mellonig J, Bowers G, Bully R. comparison of bone graft materials. New bone formation with autografts and allografts determined by strontium-85. J Periodontol. 1981;52:291-296.
28. Lynch SE. Introduction. In: Lynch SE, Genco RJ, Marx RE, eds. Tissue Engineering. Applications in Maxillofacial Surgery and Periodontics. Chicago: Quintessence; 1999.
29. Hillmann G, Geurtsen W. Tissue engineering - an exciting future. Clin Oral Invest. 2001;5:1.
30. Spector M. Basic principles of tissue engineering. In: Lynch SE, Genco RJ, Marx RE, eds. Tissue Engineering. Applications in Maxillofacial Surgery and Periodontics. Chicago: Quintessence; 1999: 3-16.
31. Baum BJ, Mooney J. The impact of tissue engineering on dentistry. JADA. 2000;131:309-318.
32. Langer R, Vacantin JP. Tissue engineering. Science. 1993;260:920-926.
33. Tozum TF, Demiralp B. Platelet-rich plasma: a promising innovation in dentistry. J Can Dent Assoc. 2003;69:664.
34. Tischler M. Platelet rich plasma. The use of autologous growth factors to enhance bone and soft tissue grafts. N Y State Dent J. 2002;68:22-24.
35. Petrungaro PS. Using platelet-rich plasma to accelerate soft tissue maturation in esthetic periodontal surgery. Compend Contin Educ Dent. 2001;22:729-736.
36. Matras H. Fibrin seal: the state of the art. J Oral Maxillofac Surg. 1985;43:605-611.
37. Tajapongsak P, O'Brien DA, Monteiro CB, et al. Autologous fibrin adhesive in mandibular reconstruction with particulate cancellous bone and marrow. J Oral Maxillofac Surg. 1994;52:161-166.
38. Shiono N, Koyama N. Application of cryoprecipitate as a hematostatic glue. J Cardiovasc Surg. 1998;39:609-612.
39. Stoney WS, Alford WC Jr. Cryoprecipitate-topical thrombin glue. Initial experience in patients undergoing cardiac operations. J Thorac Cardiovasc Surg. 1985;90:502-505.
40. Pantanowitz L, Kruskall MS. Cryoprecipitate. Patterns of use. Am J Clin Pathol. 2003;119:874-881.
41. Schofield WN, Rubin GL. Appropriateness of platelet, fresh frozen plasma and cryoprecipitate transfusion in New South Wales public hospitals. Med J Aust. 2003;178:117-121.
42. Smak Gregoor PJ, Harvey MS. Coagulation parameters of CPD fresh-frozen plasma and CPD cryoprecipitate-poor plasma after storage at 4 degrees C for 28 days. Transfusion. 1993;33:735-738.
43. Boyne PJ, James PA. Grafting of the maxillary sinus floor with autogenous marrow and bone. J Oral Surg. 1980;38:613-616.
44. Hollinger JO, Buck DC, Bruder SP. Biology of bone healing: its impact on clinical therapy. In: Lynch SE, Genco RJ, Marx RE, eds. Tissue Engineering. Applications in Maxillofacial Surgery and Periodontics. Chicago: Quintessence; 1999:17-53.
45. Verdun FR, Meuli RA. Image quality and dose in spiral computed tomography. Eur Radiol. 1996;6:485-488.
46. Wolford LM, Henry CH. Preoperative and post operative imaging evaluation of patients with maxillofacial deformities. Radiol Clin North Am. 1993;31:221-231.
47. Tolman DE. Reconstructive procedures with endosseous implants in grafted bone: a review of the literature. Int J Oral Maxillofacial Impl. 1995;10:275-294.
48. Landesberg R, Roy M, Glickman RS. Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. J Oral Maxillofac Surg. 2000;58:297-300.
49. Jensen O, Shulman L, Block M, et al. Report of the sinus conference of 1996. Int J Oral Maxillofacial Impl. 1998;13:11-45.
50. Schliephake H. Bone growth factors in maxillofacial reconstruction. Int J Oral Maxillofac Surg. 2002;31:469-484.